High constant incidence in twins and other relatives of women with breast cancer

被引:219
作者
Peto, J [1 ]
Mack, TM
机构
[1] Inst Canc Res, Epidemiol Sect, Surrey, England
[2] London Sch Hyg & Trop Med, London WC1, England
[3] USC Norris comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA USA
关键词
D O I
10.1038/82533
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The incidence of breast cancer rises steeply between ages 25 and 50, and more slowly thereafter. In contrast, the incidence in the unaffected (contralateral) breast of women who have had breast cancer remains constant at about 0.7% per year for at least the next 20 years after diagnosis, irrespective of age at first diagnosis. The incidence in relatives of the patients seems to show a similar pattern. The incidence in a prospective study of monozygotic twins of patients was approximately constant at 1.3% per year (77 cases), again about 0.7% per breast. At ages older than a patient's age at diagnosis, her mother and sisters have an incidence of 0.3-0.4% per year. Above the index patient's age at diagnosis, the rate in relatives shows no temporal trend and is independent of the patient's age at diagnosis. A statistically simple explanation is that incidence in susceptible women increases to a high constant level by a predetermined age that varies between families, but this seems inconsistent with conventional models of carcinogenesis and susceptibility. The very high incidence in monozygotic twins of patients indicates that a high proportion, and perhaps the majority, of breast cancers arise in a susceptible minority of women.
引用
收藏
页码:411 / 414
页数:4
相关论文
共 28 条
[11]  
CLAUS EB, 1988, THESIS YALE U
[12]   Intrauterine environment and breast cancer risk in women: A population-based study [J].
Ekbom, A ;
Hsieh, CC ;
Lipworth, L ;
Adami, HO ;
Trichopoulos, D .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (01) :71-76
[13]   Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].
Fisher, B ;
Costantino, JP ;
Wickerham, DL ;
Redmond, CK ;
Kavanah, M ;
Cronin, WM ;
Vogel, V ;
Robidoux, A ;
Dimitrov, N ;
Atkins, J ;
Daly, M ;
Wieand, S ;
Tan-Chiu, E ;
Ford, L ;
Wolmark, N .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388
[14]   Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families [J].
Ford, D ;
Easton, DF ;
Stratton, M ;
Narod, S ;
Goldgar, D ;
Devilee, P ;
Bishop, DT ;
Weber, B ;
Lenoir, G ;
Chang-Claude, J ;
Sobol, H ;
Teare, MD ;
Struewing, J ;
Arason, A ;
Scherneck, S ;
Peto, J ;
Rebbeck, TR ;
Tonin, P ;
Neuhausen, S ;
Barkardottir, R ;
Eyfjord, J ;
Lynch, H ;
Ponder, BAJ ;
Gayther, SA ;
Birch, JM ;
Lindblom, A ;
Stoppa-Lyonnet, D ;
Bignon, Y ;
Borg, A ;
Hamann, U ;
Haites, N ;
Scott, RJ ;
Maugard, CM ;
Vasen, H .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) :676-689
[15]  
Harvey E B, 1985, Natl Cancer Inst Monogr, V68, P99
[16]   2ND PRIMARY CANCERS OF THE BREAST - INCIDENCE AND RISK-FACTORS [J].
HISLOP, TG ;
ELWOOD, JM ;
COLDMAN, AJ ;
SPINELLI, JJ ;
WORTH, AJ ;
ELLISON, LG .
BRITISH JOURNAL OF CANCER, 1984, 49 (01) :79-85
[17]  
Houlston Richard S., 1996, P208
[18]   Cancer risk in close relatives of women with early-onset breast cancer -: a population-based incidence study [J].
Olsen, JH ;
Seersholm, N ;
Boice, JD ;
Kjær, SK ;
Fraumeni, JF .
BRITISH JOURNAL OF CANCER, 1999, 79 (3-4) :673-679
[19]   Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer [J].
Peto, J ;
Collins, N ;
Barfoot, R ;
Seal, S ;
Warren, W ;
Rahman, N ;
Easton, DF ;
Evans, C ;
Deacon, J ;
Stratton, MR .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (11) :943-949
[20]  
Peto J, 1996, INT J CANCER, V65, P275, DOI 10.1002/(SICI)1097-0215(19960126)65:3&lt